Aldeyra Therapeutics, Inc. (ALDX)
1.78
-0.02
(-1.11%)
USD |
NASDAQ |
Apr 20, 09:50
Aldeyra Therapeutics SG&A Expense (Quarterly) : 2.364M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Rhythm Pharmaceuticals, Inc. | 57.48M |
| Pfizer Inc. | 4.162B |
| Catalyst Pharmaceuticals, Inc. | 48.23M |
| MediciNova, Inc. | 1.554M |
| ADMA Biologics, Inc. | 24.64M |